Bluepharma was recognized as ESG Reporting Pioneer by the Portal SIBS ESG.

Bluepharma Group is today one of the most entrepreneurial and innovative in the pharmaceutical sector, having already achieved a remarkable prestige not only in Portugal, but also in the most demanding international markets. Throughout its 25 years, Bluepharma has transformed an industrial unit that employs 58 people, in an economic group of 20 companies and more than 700 employees. It has opened offices in 3 countries (Angola, Mozambique and USA) and exported, in 2025, 89% of its production to more than 40 countries. Bluepharma's activity goes through the entire value chain of the drug, from R&D to the market, imposing itself for the excellence of its production unit, the quality and training of its employees and the experience and dynamism of its management team.